We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current SES market cap is 22.67M. The company's latest EPS is AUD -0.0156 and P/E is -1.28.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 21.04M | 30.08M | 31.04M | 22.84M | 16.16M |
| Operating Income | -885k | 673k | -2.72M | -5.57M | -8.32M |
| Net Income | -1.19M | 2.59M | -3.09M | -6.75M | -9.33M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 15.75M | 33.77M | 33.22M | 27.96M | 18.05M |
| Total Liabilities | 4.38M | 4.55M | 6.55M | 4.83M | 4.02M |
| Total Equity | 11.38M | 29.22M | 26.67M | 23.13M | 14.03M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -650k | -4.7M | -4.06M | 2.02M | -1.29M |
| Investing | -493k | -1.15M | -2.44M | -639k | -302k |
| Financing | 1.15M | 14.39M | -747k | 2.94M | -719k |
| Market Cap | 22.67M |
| Price to Earnings Ratio | -1.28 |
| Price to Sales Ratio | 0.74 |
| Price to Cash Ratio | 1.96 |
| Price to Book Ratio | 0.85 |
| Dividend Yield | - |
| Shares Outstanding | 596.61M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 5.56% |
| 52 Week High | 0.045 |
| 52 Week Low | 0.017 |
| Spread (Intraday) | 0 (5%) |
| Company Name | SECOS Group Limited |
| Address |
unit 1 melbourne, victoria 3149 |
| Website | https://wwwsecosgroup.com.au |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
